Multiple sclerosis: open trials in Denmark

• NCT07067463

  A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

  Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC

  Aalborg University Hospital, Gistrup · Region Midtjylland, Viborg

  Registry updated 2026-11-03

• 2023-504358-36-00

  Efficacy and safety study of frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis

  Trial Treatment · Phase 3 · Sanofi-Aventis Recherche & Developpement

  Esbjerg Sygehus, Esbjerg · Rigshospitalet, Glostrup

  Registry updated 2026-10-28

• NCT07299019

  A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

  Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC

  Aalborg University Hospital, Gistrup · Region Midtjylland, Viborg

  Registry updated 2026-10-27

• NCT06846281

  Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Region Midtjylland, Aarhus N · Rigshospitalet, Glostrup

  Registry updated 2026-10-26

• 2024-512914-16-00

  A Randomized, Double-blind, Study to Demonstrate Pharmacokinetic Similarity, and Evaluate Safety, Immunogenicity, Pharmacodynamics and Clinical Effects between ABP 692 and Ocrevus® (Ocrelizumab) in Subjects with Relapsing-remitting Multiple Sclerosis

  Trial Treatment · Phase 3 · Amgen Inc.

  Rigshospitalet, Glostrup

  Registry updated 2026-10-20

• NCT05380856

  Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction

  Trial Treatment · Odense University Hospital

  Odense University Hospital, Odense

  Registry updated 2026-10-16

• NCT07225504

  A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Novartis Investigative Site, Aarhus N · Novartis Investigative Site, Esbjerg · Novartis Investigative Site, Glostrup Municipality · Novartis Investigative Site, Odense C

  Registry updated 2026-10-13

• NCT07325292

  Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

  Trial Treatment · Phase 3 · Sanofi

  Esbjerg Og Grindsted Sygehus, Esbjerg · Region Hovedstaden, Glostrup

  Registry updated 2026-10-13

• NCT07202195

  At Home Use of Stimulation Suits for Managing MS Symptoms

  Trial Treatment · Daphne Kos

  The Danish MS Hospitals, Ry

  Registry updated 2026-10-08

• NCT06569550

  Fatigue Alleviation Through Neuromodulating Therapy in Multiple Sclerosis

  Trial Treatment · Danish Research Centre for Magnetic Resonance

  Danish Research Centre for Magnetic Resonance, Hvidovre

  Registry updated 2026-09-22

• 2024-512707-40-00

  A Phase 2 Study of Obexelimab in Patients with Relapsing Multiple Sclerosis

  Trial Treatment · Phase 2 · Zenas Biopharma (USA) LLC

  Region Nordjylland, Gistrup

  Registry updated 2026-08-27

• 2025-521546-23-00

  A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis

  Trial Treatment · Phase 3 · Novartis Pharma AG

  Region Midtjylland, Aarhus N · Esbjerg Og Grindsted Sygehus, Esbjerg · Rigshospitalet, Glostrup · Odense University Hospital, Odense C

  Registry updated 2026-07-30

• NCT06782724

  Psilocybin Therapy for Psychological Distress in Palliative Patients

  Trial Treatment · Phase 2 · University Medical Center Groningen

  Region Hovedstaden, Copenhagen Nv

  Registry updated 2026-05-08

• NCT07318129

  Indole-3-PROpionic Acid Clinical Trials - Multiple Sclerosis

  Trial Treatment · Glostrup University Hospital, Copenhagen

  Glostrup Hospital, Glostrup Municipality

  Registry updated 2026-01-28

• NCT07342777

  EXpain Trial - Exercise an a Non-pharmacological Pain-relieving Treatment in People With Multiple Sclerosis

  Trial Treatment · University of Aarhus

  Aarhus University, Aarhus

  Registry updated 2026-01-15

• NCT07304375

  Effects of Exercise and Sleep on Motor Learning and Functional Abilities in Multiple Sclerosis

  Trial Treatment · Zealand University Hospital

  Section of Movement and Neuroscience, Department of Nutrition, Exercise, and Sports, University of Copenhagen, Copenhagen · Zealand University Hospital, Roskilde, Roskilde

  Registry updated 2026-01-08

• NCT07310914

  Implementation of an Advanced Telerehabilitation Solution for People With Multiple Sclerosis

  Trial Treatment · Phase 2 · Danish Multiple Sclerosis Hospitals

  The Danish MS Hospitals, Haslev, Haslev · The Danish MS Hospitals, Ry, Ry

  Registry updated 2025-12-30

• NCT06956326

  Illuminating New Paths in the Treatment of Multiple Sclerosis Relapses - Early and Specialized Rehabilitation

  Trial Treatment · Phase 2 · Lars Hvid

  The Danish MS Hospitals, Haslev · The Danish MS Hospitals, Ry

  Registry updated 2025-05-04

• NCT06374108

  Resistance Training and Corticospinal Excitability in Multiple Sclerosis

  Trial Treatment · University of Aarhus

  Department of Public Health, Aarhus · Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen

  Registry updated 2024-12-11

All Multiple sclerosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error